Clinical trial

Hypoxia-altitude Testing to Predict Altitude Related Adverse Health Effects in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT04915378

Study summary

ClinicalTrials.gov

Hypoxia-altitude Testing to Predict Altitude Related Adverse Health Effects in Chronic Obstructive Pulmonary Disease (COPD) Patients

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention hypoxia altitude simulation test (HAST) at 760m Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention High Altitude (3100m) Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2021-06-01

PhaseN/A

Conditions

Hypoxia Altitude Simulation Testunresolved

High Altitudeunresolved

Interventions

hypoxia altitude simulation test (HAST) at 760mOTHER

High Altitude (3100m)PROCEDURE

Sponsors & collaborators

University of Zurichlead sponsor

National Center of Cardiology and Internal Medicine, Kyrgyz Republiccollaborator

Mapped research locations

BishkekKyrgyzstan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04915378 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.